This methylation state can be used to distinguish IDH-mutant astrocytoma from other forms of diffusely infiltrating gliomas and other CNS neoplasms, and predict clinical outcomes [33, 34, 74, 108, 183, 227]. The gene discussed is IDH2; the disease is astrocytoma (excluding glioblastoma).